Thanks to the use of fossil free energy during their production and their lighter weight, Metsä Board’s folding boxboards allow to reduce significantly the carbon footprint of packaging.
Assessments [1] conducted by Metsä Board demonstrate the significant carbon footprint reductions that pharmaceutical manufacturers can achieve by switching from commonly used grades to Metsä Board fresh fibre paperboards.
Indeed, switching from a solid bleached board (SBB) to Metsä Board folding boxboard can reduce the carbon footprint of packaging by over 50%, and replacing white lined chipboard (WLC) with Metsä Board folding boxboard can result in a 60% reduction or even higher. These assessments have been verified by IVL Swedish Environmental Research Institute. The technical background report and the verification statement are available on Metsä Board’s website.
Despite the lighter weight, Metsä Board’s folding boxboards still retain the durability and functional properties of traditional heavier grades.
“As a responsible materials supplier it is our job to provide pharma brand owners with transparent, unbiased information that helps them evaluate packaging materials to make better-informed and sustainable choices to reduce their carbon footprint,” says Anne Uusitalo, Product Safety and Sustainability Director at Metsä Board.
